Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marianne Baastrup Søndergaard1, Frederik Roager Madsen1, Asger Sverrild1

  • 1Lunge- og Infektionsmedicinsk Afdeling, Københavns Universitetshospital - Bispebjerg og Frederiksberg Hospital.

Ugeskrift for Laeger
|April 12, 2024
PubMed
Summary

Treatments for obstructive lung diseases like asthma and COPD have advanced significantly with inhaled corticosteroids and biologics. Future care will focus on personalized medicine in specialized centers for severe cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.

The Lancet. Respiratory medicine·2026
Same author

From mild-to-moderate to severe asthma: Risk factors and patient profiles from the NORDSTAR cohort.

American journal of respiratory and critical care medicine·2026
Same author

Azithromycin enhances epithelial antiviral immunity in uncontrolled asthma: results from the AZIMUNE randomized controlled trial.

The European respiratory journal·2026
Same author

Five-year inhaled, systemic, and total corticosteroid exposure reduction during anti‒interleukin-5 receptor alpha treatment for severe asthma.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Dupilumab for Chronic Spontaneous Urticaria with Comorbid Type 2 Inflammatory Conditions: Case Report and Systematic Review of the Literature.

Case reports in dermatology·2026
Same author

Cumulative corticosteroid burden over 25 years in patients initiating biologic therapy for severe asthma: a nationwide cohort study.

ERJ open research·2026

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Therapeutics

Background:

  • Significant advancements in treating obstructive lung diseases over the past 30 years.
  • Revolutionary impact of inhaled corticosteroids (ICS) and biological treatments on asthma and COPD care.
  • Biological treatments show high efficacy in severe asthma, with anticipated approval for COPD.

Approach:

  • Systematic assessment and multidimensional treatment strategies are essential for managing asthma and COPD.
  • Review of current therapeutic landscape and future directions in obstructive lung disease management.
  • Exploration of personalized medicine approaches for complex respiratory conditions.

Key Points:

  • Inhaled corticosteroids (ICS) and biologics have transformed obstructive lung disease treatment.
  • Biological therapies are highly effective for severe asthma and nearing COPD application.
  • Multidimensional and systematic approaches are critical for optimal patient outcomes.
  • Personalized treatment strategies are key for managing severe obstructive lung diseases.

Conclusions:

  • Future management of severe obstructive lung diseases will likely involve specialized centers.
  • Focus on personalized approaches and continuous monitoring will define advanced respiratory care.
  • Integration of novel therapies and tailored strategies promises improved outcomes for patients with asthma and COPD.

Related Experiment Videos